Akron Pharma, Inc. has recalled approximately 10,845 bottles of OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL), a stool softener laxative sold in 16 FL OZ (473 mL) bottles. The recall was issued because the products were manufactured under conditions that deviated from Current Good Manufacturing Practice (CGMP) standards. No injuries or adverse health events have been reported in connection with this recall.
Deviations from manufacturing standards can result in products that do not meet quality specifications for purity or potency. Using a drug that does not meet these standards may lead to ineffective treatment or unexpected health risks, though the immediate risk of serious injury in this case is considered remote.
You have 2 options:
Manufactured for Akron Pharma, Inc., Fairfield, NJ 07004.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.